Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Seborrheic Keratosis: later-stage trial registry
1 of 3 indexed Seborrheic Keratosis trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Seborrheic Keratosis: 3 US clinical trials tracked, 1 recruiting.
Seborrheic Keratosis is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Aclaris Therapeutics, running 2 of these trials.
Enrollment posture brief
Registry condition seborrheic-keratosis
OPEN 1 | RECR 33% | LATE 2 | EARLY 1 | RANK #5209 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Seborrheic Keratosis lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Seborrheic Keratosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Seborrheic Keratosis is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis
DermBiont
NCT06108024
A Randomized, Double-Blind, Vehicle-Controlled Study in Subjects With Seborrheic Keratosis
Aclaris Therapeutics
NCT02667275
A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis.
Aclaris Therapeutics
NCT02667236
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Seborrheic Keratosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Seborrheic Keratosis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Seborrheic Keratosis page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Seborrheic Keratosis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Aclaris Therapeutics sponsors the most Seborrheic Keratosis trials on record, review their full trial history before evaluating a specific study. See Aclaris Therapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Seborrheic Keratosis condition card totals 3 registered trials; most-linked intervention Vehicle Solution; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.